Immagina Biotech and Tri-I Biotech announce distribution agreement

Immagina Biotech is very pleased to announce the appointment of Tri-I Biotech Inc as its official distributor in Taiwan to further expand and grow its business operations in Asia.

Nature Pubblication: SMN-primed ribosomes modulate the translation of transcripts related to Spinal Muscular Atrophy

RiboLace to study Spinal Muscular Atrophy.
SMN-primed ribosomes modulate the translation of transcripts related to Spinal Muscular Atrophy

Winners of the Immagina Ribo-Omics Grant Challenge 2020.

We are excited to share the winners of the
Immagina Ribo-Omics Grant Challenge 2020.

Online webinar: Spinal Muscular Atrophy: lost in translation?

IMMAGINA BIOTECHNOLOGY and TomaLab are excited to host a series of free live scientific webinars. During the webinars, prestigious speakers will present their recent researches carried out by the use of IMMAGINA BIOTECH products for the study of translational control of gene expression and diseases.

Officially announcing the collaboration between IMMAGINA Biotechnology and Genexa!

We are working together to develop a powerful data analysis tool for the only product available for 3’ phospho-RNA sequencing with ONT platform, CircAID-p-seq! Genexa is a service provider for bioinformatic analyses based in Zurich, Switzerland. Genexa’s services are centered around the analysis of third- and next-generation genomics data and the development of novel data […]

EIT headstart grant to investigate circAID-p-seq applications in the pharma sector

We are glad to announce that we were awarded the EIT headstart grant to further investigate circAID-p-seq applications in the pharma sector

Immagina poster at RNA2020

One-shot analysis of translated mammalian lncRNAs with AHARIBO

In February 2020 IMMAGINA BioTechnology raised 1M Euro from existing investors and new, undisclosed EU-based investors. The Company has raised about 2M Euro to date

In February 2020 IMMAGINA raised 1 M Euro from existing investors and new, undisclosed EU-based investors. The Company has raised about 2 M Euro to date

Scientific publication – IMMAGINA new tools on bioRxiv – 10/2018

Our preprint work describing new probes to sense the activity of protein synthesis and to capture associated RNA is now available on bioRxiv

Immagina Biotechnology has been featured by… (2017)

The Next Tech – World Cancer Day   And local media are sometimes important to help the local business community…